Dapavo P, Megna M, Talamonti M. Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate to severe plaque psoriasis. Dermatol Reports [Internet]. 2024 Aug. 9 [cited 2024 Dec. 4];. Available from: https://www.pagepress.org/journals/dr/article/view/9999